22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
05/03/21 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/05/21 | DEF 14A | Definitive proxy statements |
![]() |
58 | |
04/01/21 | 4/A | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/01/21 | 4/A | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
03/31/21 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
03/23/21 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
03/23/21 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
03/23/21 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
03/22/21 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
03/22/21 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 |